ID

35857

Beschreibung

Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5; ODM derived from: https://clinicaltrials.gov/show/NCT02392208

Link

https://clinicaltrials.gov/show/NCT02392208

Stichworte

  1. 28.03.19 28.03.19 -
  2. 20.09.21 20.09.21 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

28. März 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility End-Stage Renal Disease NCT02392208

Eligibility End-Stage Renal Disease NCT02392208

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
≥ 18 years of age
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
within 50 - 150 % of ideal body weight and greater than 40 kg
Beschreibung

Percentage Ideal Body Weight | Body Weight

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0439165
UMLS CUI [1,2]
C0421272
UMLS CUI [2]
C0005910
ckd5 receiving maintenance hemodialysis for ≥ 3 months
Beschreibung

Chronic Kidney Disease Stage | Maintenance hemodialysis

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1561643
UMLS CUI [1,2]
C2074731
UMLS CUI [2]
C4040576
creatinine clearance estimate < 10 ml/min
Beschreibung

Estimation of creatinine clearance by Cockcroft-Gault formula

Datentyp

boolean

Alias
UMLS CUI [1]
C2711451
not received telavancin within the past month
Beschreibung

Telavancin Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1453642
UMLS CUI [1,2]
C0332197
no concurrent illness or evidence of infection
Beschreibung

Comorbidity Absent | Communicable Disease Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0009450
UMLS CUI [2,2]
C0332197
able to give informed consent
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
pre-study hemoglobin < 9.0 g/dl
Beschreibung

Hemoglobin measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0518015
plasma albumin < 2.5 g/dl
Beschreibung

Measurement of albumin in plasma

Datentyp

boolean

Alias
UMLS CUI [1]
C3525688
pregnancy
Beschreibung

Pregnancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
breastfeeding
Beschreibung

Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0006147
qtc interval > 470 msec on ekg obtained within the last 6 months
Beschreibung

Prolonged QTc interval on ECG

Datentyp

boolean

Alias
UMLS CUI [1]
C4015677
receiving concomitant qt prolonging agents
Beschreibung

Pharmaceutical Preparations Causing Prolonged QT interval

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0678227
UMLS CUI [1,3]
C0151878
receiving warfarin or low molecular weight heparin products
Beschreibung

Warfarin | Heparin, Low-Molecular-Weight

Datentyp

boolean

Alias
UMLS CUI [1]
C0043031
UMLS CUI [2]
C0019139
known allergy to telavancin or vancomycin
Beschreibung

Hypersensitivity Telavancin | Vancomycin allergy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1453642
UMLS CUI [2]
C0571388
unstable blood pressure control
Beschreibung

Unstable blood pressure Control

Datentyp

boolean

Alias
UMLS CUI [1,1]
C4540782
UMLS CUI [1,2]
C2587213
need for routine large fluid removal during dialysis (> 4 liters)
Beschreibung

Patient need for Removal Fluid Large | Dialysis procedure

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0686904
UMLS CUI [1,2]
C1883720
UMLS CUI [1,3]
C0005889
UMLS CUI [1,4]
C0549177
UMLS CUI [2]
C0011946
diagnosis of liver disease with a child pugh score of c or higher
Beschreibung

Liver disease Child-Pugh Classification

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C2347612
dialysis isolation requirements due to hepatitis b
Beschreibung

Dialysis | Need for isolation Due to Hepatitis B

Datentyp

boolean

Alias
UMLS CUI [1]
C0011946
UMLS CUI [2,1]
C0260397
UMLS CUI [2,2]
C0678226
UMLS CUI [2,3]
C0019163
participating concurrently in another investigational drug study
Beschreibung

Study Subject Participation Status | Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230

Ähnliche Modelle

Eligibility End-Stage Renal Disease NCT02392208

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
≥ 18 years of age
boolean
C0001779 (UMLS CUI [1])
Percentage Ideal Body Weight | Body Weight
Item
within 50 - 150 % of ideal body weight and greater than 40 kg
boolean
C0439165 (UMLS CUI [1,1])
C0421272 (UMLS CUI [1,2])
C0005910 (UMLS CUI [2])
Chronic Kidney Disease Stage | Maintenance hemodialysis
Item
ckd5 receiving maintenance hemodialysis for ≥ 3 months
boolean
C1561643 (UMLS CUI [1,1])
C2074731 (UMLS CUI [1,2])
C4040576 (UMLS CUI [2])
Estimation of creatinine clearance by Cockcroft-Gault formula
Item
creatinine clearance estimate < 10 ml/min
boolean
C2711451 (UMLS CUI [1])
Telavancin Absent
Item
not received telavancin within the past month
boolean
C1453642 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Comorbidity Absent | Communicable Disease Absent
Item
no concurrent illness or evidence of infection
boolean
C0009488 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0009450 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Informed Consent
Item
able to give informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Hemoglobin measurement
Item
pre-study hemoglobin < 9.0 g/dl
boolean
C0518015 (UMLS CUI [1])
Measurement of albumin in plasma
Item
plasma albumin < 2.5 g/dl
boolean
C3525688 (UMLS CUI [1])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Breast Feeding
Item
breastfeeding
boolean
C0006147 (UMLS CUI [1])
Prolonged QTc interval on ECG
Item
qtc interval > 470 msec on ekg obtained within the last 6 months
boolean
C4015677 (UMLS CUI [1])
Pharmaceutical Preparations Causing Prolonged QT interval
Item
receiving concomitant qt prolonging agents
boolean
C0013227 (UMLS CUI [1,1])
C0678227 (UMLS CUI [1,2])
C0151878 (UMLS CUI [1,3])
Warfarin | Heparin, Low-Molecular-Weight
Item
receiving warfarin or low molecular weight heparin products
boolean
C0043031 (UMLS CUI [1])
C0019139 (UMLS CUI [2])
Hypersensitivity Telavancin | Vancomycin allergy
Item
known allergy to telavancin or vancomycin
boolean
C0020517 (UMLS CUI [1,1])
C1453642 (UMLS CUI [1,2])
C0571388 (UMLS CUI [2])
Unstable blood pressure Control
Item
unstable blood pressure control
boolean
C4540782 (UMLS CUI [1,1])
C2587213 (UMLS CUI [1,2])
Patient need for Removal Fluid Large | Dialysis procedure
Item
need for routine large fluid removal during dialysis (> 4 liters)
boolean
C0686904 (UMLS CUI [1,1])
C1883720 (UMLS CUI [1,2])
C0005889 (UMLS CUI [1,3])
C0549177 (UMLS CUI [1,4])
C0011946 (UMLS CUI [2])
Liver disease Child-Pugh Classification
Item
diagnosis of liver disease with a child pugh score of c or higher
boolean
C0023895 (UMLS CUI [1,1])
C2347612 (UMLS CUI [1,2])
Dialysis | Need for isolation Due to Hepatitis B
Item
dialysis isolation requirements due to hepatitis b
boolean
C0011946 (UMLS CUI [1])
C0260397 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0019163 (UMLS CUI [2,3])
Study Subject Participation Status | Investigational New Drugs
Item
participating concurrently in another investigational drug study
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video